ABP - Abpro Holdings, Inc.
0.522
-0.278 -53.276%
Share volume: 3,258,991
Last Updated: 02-20-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.28
-0.35%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2025 | 11-14-2025 | |
| Total revenue | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | |
| nan% | |||
| Operating expenses | 2.958 M | 1.336 M | |
| Selling general and admin | 2.633 M | 1.093 M | |
| Research and development | 325.000 K | 243.000 K | |
| Total expenses | 2.958 M | 1.336 M | |
| -54.83% | |||
| Operating income | -2.958 M | -1.336 M | |
| Ebit | -3.168 M | -1.470 M | |
| Pretax income | -3.887 M | -1.657 M | |
| -57.37% | |||
| Income tax | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | |
| Net income | -3.887 M | -1.657 M | |
| 57.37% |